DE3514724A1 - Salbe zur verbeugung und behandlung von augen- und hauterkrankungen - Google Patents

Salbe zur verbeugung und behandlung von augen- und hauterkrankungen

Info

Publication number
DE3514724A1
DE3514724A1 DE19853514724 DE3514724A DE3514724A1 DE 3514724 A1 DE3514724 A1 DE 3514724A1 DE 19853514724 DE19853514724 DE 19853514724 DE 3514724 A DE3514724 A DE 3514724A DE 3514724 A1 DE3514724 A1 DE 3514724A1
Authority
DE
Germany
Prior art keywords
vitamin
ointment
treatment
skin
disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE19853514724
Other languages
German (de)
English (en)
Other versions
DE3514724C2 (enrdf_load_stackoverflow
Inventor
Albin F. Dr. 4200 Oberhausen Jereb
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to DE19853514724 priority Critical patent/DE3514724A1/de
Publication of DE3514724A1 publication Critical patent/DE3514724A1/de
Application granted granted Critical
Publication of DE3514724C2 publication Critical patent/DE3514724C2/de
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/23—Sulfur; Selenium; Tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/673—Vitamin B group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/676—Ascorbic acid, i.e. vitamin C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/678—Tocopherol, i.e. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/008—Preparations for oily skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
DE19853514724 1985-04-24 1985-04-24 Salbe zur verbeugung und behandlung von augen- und hauterkrankungen Granted DE3514724A1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE19853514724 DE3514724A1 (de) 1985-04-24 1985-04-24 Salbe zur verbeugung und behandlung von augen- und hauterkrankungen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19853514724 DE3514724A1 (de) 1985-04-24 1985-04-24 Salbe zur verbeugung und behandlung von augen- und hauterkrankungen

Publications (2)

Publication Number Publication Date
DE3514724A1 true DE3514724A1 (de) 1986-10-30
DE3514724C2 DE3514724C2 (enrdf_load_stackoverflow) 1989-10-26

Family

ID=6268943

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19853514724 Granted DE3514724A1 (de) 1985-04-24 1985-04-24 Salbe zur verbeugung und behandlung von augen- und hauterkrankungen

Country Status (1)

Country Link
DE (1) DE3514724A1 (enrdf_load_stackoverflow)

Cited By (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0545759A1 (fr) * 1991-11-28 1993-06-09 Société BFB Utilisation d'un acide aminé soufré, éventuellement en association avec la pyridoxine, pour la préparation d'un médicament destiné au traitement de l'eczéma
DE19521684A1 (de) * 1994-07-26 1996-12-19 Kang Meng Che Pharmazeutische Zusammensetzung zur ophthalmologischen Anwendung
FR2738743A1 (fr) * 1995-09-19 1997-03-21 Oreal Utilisation de l'acide ascorbique comme actif pour le traitement de la seborrhee dans une composition cosmetique et/ou dermatologique
EP0727985A4 (en) * 1993-10-22 1997-07-02 Melvin L Elson PREPARATION AND METHOD FOR TREATING SKIN DISEASES OF THE SKIN USING VITAMIN K
EP0771555A4 (en) * 1994-08-03 1998-04-01 Zhanna Prokofievna Gudzenko AGENT FOR EXTERNAL APPLICATION NUTRITIONAL AND PROTECTIVE PROPERTIES
US5972993A (en) * 1998-03-20 1999-10-26 Avon Products, Inc. Composition and method for treating rosacea and sensitive skin with free radical scavengers
CN1054741C (zh) * 1995-10-09 2000-07-26 康孟喆 眼用医药组合物
EP0862916A4 (en) * 1995-11-20 2001-01-10 Kiyoshi Kita EXTERNAL PREPARATION CONTAINING VITAMIN D OR VITAMIN K
US6461622B2 (en) 1994-09-07 2002-10-08 Johnson & Johnson Consumer Companies, Inc. Topical compositions
US6531141B1 (en) 2000-03-07 2003-03-11 Ortho-Mcneil Pharmaceutical, Inc. Oil-in-water emulsion containing tretinoin
EP1433481A1 (en) * 2002-12-23 2004-06-30 Liang Youguo The use of methyltestosterone for the treatment of human papilloma virus infections
EP1027045A4 (en) * 1997-10-31 2004-12-08 Arch Dev Corp METHODS AND COMPILATIONS FOR REGULATING S-ALPHA REDUCTASE ACTIVITY
US6833141B1 (en) * 2003-07-11 2004-12-21 Joseph L. Owades Method of treating pruritis and composition thereof
USRE38813E1 (en) 1990-01-29 2005-10-04 Johnson & Johnson Consumer Companies, Inc. Retinoid compositions containing a water soluble antioxidant and a chelator
EP1594510A4 (en) * 2003-01-21 2008-07-23 Dimera Inc METHOD AND KIT FOR REDUCING SYMPTOMS OF DISORDERS OF THE PERIPHERAL VASCULAR SYSTEM
WO2009114745A1 (en) * 2008-03-13 2009-09-17 Hana Biosciences, Inc. Formulations of vitamin k analogs for topical use
EP2124958A4 (en) * 2006-12-05 2009-12-30 Southern College Of Optometry TREATMENT OF IL DR SYNDROME BY EMPLOYING TESTOSTERONE AND PROGESTAGEN
US7745494B2 (en) 2005-04-15 2010-06-29 Albert Einstein College Of Medicine Of Yeshiva University Vitamin K for prevention and treatment of skin rash secondary to anti-EGFR therapy
WO2012103186A3 (en) * 2011-01-26 2012-09-20 Allergan, Inc. Androgen composition for treating an opthalmic condition
US9428582B2 (en) 2006-07-03 2016-08-30 Genmab A/S Method of treating rash in patients undergoing anti-EGFR therapy
US9458236B2 (en) 2001-06-13 2016-10-04 Genmab A/S Human monoclonal antibodies to epidermal growth factor receptor (EGFR)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100250700B1 (ko) † 1991-06-27 2000-07-01 차알스 제이. 메츠 안정화된 레티노이드 함유 피부 보호용 조성물

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2240187A1 (de) * 1972-08-16 1974-02-21 Jereb Franz Dr Albin Salbe

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2240187A1 (de) * 1972-08-16 1974-02-21 Jereb Franz Dr Albin Salbe

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
HELWIG: Moderne Arzneimittelwiss. Verlagsges. mbH, Stuttgart, 1980, S.1057 u. 1219 *
The-Merck-Index, 10.Ed. 1983, Nr.5662 u. 8858 *

Cited By (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE38813E1 (en) 1990-01-29 2005-10-04 Johnson & Johnson Consumer Companies, Inc. Retinoid compositions containing a water soluble antioxidant and a chelator
EP0545759A1 (fr) * 1991-11-28 1993-06-09 Société BFB Utilisation d'un acide aminé soufré, éventuellement en association avec la pyridoxine, pour la préparation d'un médicament destiné au traitement de l'eczéma
EP0727985A4 (en) * 1993-10-22 1997-07-02 Melvin L Elson PREPARATION AND METHOD FOR TREATING SKIN DISEASES OF THE SKIN USING VITAMIN K
DE19521684C2 (de) * 1994-07-26 1999-09-02 Kang Pharmazeutische Zusammensetzung zur ophthalmologischen Anwendung
DE19521684A1 (de) * 1994-07-26 1996-12-19 Kang Meng Che Pharmazeutische Zusammensetzung zur ophthalmologischen Anwendung
EP0771555A4 (en) * 1994-08-03 1998-04-01 Zhanna Prokofievna Gudzenko AGENT FOR EXTERNAL APPLICATION NUTRITIONAL AND PROTECTIVE PROPERTIES
US6461622B2 (en) 1994-09-07 2002-10-08 Johnson & Johnson Consumer Companies, Inc. Topical compositions
JPH09110628A (ja) * 1995-09-19 1997-04-28 L'oreal Sa 脂漏症を処理するための活性剤としてアスコルビン酸を含む化粧用および／または皮膚科学用組成物
EP0771557A1 (fr) * 1995-09-19 1997-05-07 L'oreal Utilisation de l'acide ascorbique comme actif pour le traitement de la séborrhée dans une composition cosmétique et/ou dermatologique
FR2738743A1 (fr) * 1995-09-19 1997-03-21 Oreal Utilisation de l'acide ascorbique comme actif pour le traitement de la seborrhee dans une composition cosmetique et/ou dermatologique
CN1054741C (zh) * 1995-10-09 2000-07-26 康孟喆 眼用医药组合物
EP0862916A4 (en) * 1995-11-20 2001-01-10 Kiyoshi Kita EXTERNAL PREPARATION CONTAINING VITAMIN D OR VITAMIN K
EP1027045A4 (en) * 1997-10-31 2004-12-08 Arch Dev Corp METHODS AND COMPILATIONS FOR REGULATING S-ALPHA REDUCTASE ACTIVITY
US5972993A (en) * 1998-03-20 1999-10-26 Avon Products, Inc. Composition and method for treating rosacea and sensitive skin with free radical scavengers
US6531141B1 (en) 2000-03-07 2003-03-11 Ortho-Mcneil Pharmaceutical, Inc. Oil-in-water emulsion containing tretinoin
US9458236B2 (en) 2001-06-13 2016-10-04 Genmab A/S Human monoclonal antibodies to epidermal growth factor receptor (EGFR)
EP1433481A1 (en) * 2002-12-23 2004-06-30 Liang Youguo The use of methyltestosterone for the treatment of human papilloma virus infections
US7572780B2 (en) 2003-01-21 2009-08-11 Dimera, Incorporated Method and kit for reducing the symptoms of peripheral vascular disease
US8182833B2 (en) 2003-01-21 2012-05-22 Dimera Incorporated Method and kit for reducing the symptoms of peripheral vascular disease with topical progesterone
US8420111B2 (en) 2003-01-21 2013-04-16 Dimera Incorporated Method and kit for reducing the symptoms of peripheral vascular disease
EP1594510A4 (en) * 2003-01-21 2008-07-23 Dimera Inc METHOD AND KIT FOR REDUCING SYMPTOMS OF DISORDERS OF THE PERIPHERAL VASCULAR SYSTEM
US6833141B1 (en) * 2003-07-11 2004-12-21 Joseph L. Owades Method of treating pruritis and composition thereof
US7745494B2 (en) 2005-04-15 2010-06-29 Albert Einstein College Of Medicine Of Yeshiva University Vitamin K for prevention and treatment of skin rash secondary to anti-EGFR therapy
US8283382B2 (en) 2005-04-15 2012-10-09 Albert Einstein College Of Medicine Of Yeshiva University Vitamin K for prevention and treatment of skin rash secondary to anti-EGFR therapy
US9428582B2 (en) 2006-07-03 2016-08-30 Genmab A/S Method of treating rash in patients undergoing anti-EGFR therapy
EP2124958A4 (en) * 2006-12-05 2009-12-30 Southern College Of Optometry TREATMENT OF IL DR SYNDROME BY EMPLOYING TESTOSTERONE AND PROGESTAGEN
EP2101785A4 (en) * 2006-12-05 2009-12-30 Southern College Of Optometry TREATMENT OF IT SEC
WO2009114745A1 (en) * 2008-03-13 2009-09-17 Hana Biosciences, Inc. Formulations of vitamin k analogs for topical use
US8815953B2 (en) 2008-03-13 2014-08-26 Spectrum Pharmaceuticals, Inc. Formulations of vitamin K analogs for topical use
US9119772B2 (en) 2011-01-26 2015-09-01 Allergan, Inc. Androgen composition for treating an opthalmic condition
WO2012103186A3 (en) * 2011-01-26 2012-09-20 Allergan, Inc. Androgen composition for treating an opthalmic condition
RU2599036C2 (ru) * 2011-01-26 2016-10-10 Аллерган, Инк. Андрогенная композиция для лечения офтальмологического заболевания
US9504646B2 (en) 2011-01-26 2016-11-29 Allergan, Inc. Androgen composition for treating an opthalmic condition
AU2012209184B2 (en) * 2011-01-26 2017-06-15 Allergan, Inc. Androgen composition for treating an opthalmic condition
US9937188B2 (en) 2011-01-26 2018-04-10 Allergan, Inc. Non-irritating testosterone emulsions
EP3388066A1 (en) * 2011-01-26 2018-10-17 Allergan, Inc. Androgen composition for treating an opthalmic condition
US10780098B2 (en) 2011-01-26 2020-09-22 Allergan, Inc. Non-irritating testosterone emulsions
US10905696B2 (en) 2011-01-26 2021-02-02 Allergan, Inc. Androgen composition for treating an ophthalmic condition

Also Published As

Publication number Publication date
DE3514724C2 (enrdf_load_stackoverflow) 1989-10-26

Similar Documents

Publication Publication Date Title
DE3514724A1 (de) Salbe zur verbeugung und behandlung von augen- und hauterkrankungen
AT406731B (de) Stoffgemisch zur topischen anwendung
DE3784522T2 (de) Medizinische zusammensetzungen gegen psoriasis.
DE69221686T2 (de) Therapeutische und kosmetische zusammensetzungen zur hautbehandlung
DE2802924C2 (de) Arzneimittel zur Behandlung von Akne
DE2046119A1 (de) Mitte) zur Behandlung der Akne
EP0209724B1 (de) Präparat mit Wirkung gegen Akne sowie Verwendung von Wirkstoffextrakt des Queckenweizens
DE2240187A1 (de) Salbe
DE3784695T2 (de) Gebrauch von Gramineenextrakten als Arzneimittel.
DE69005062T2 (de) Fettsäuren zur Behandlung und Prävention von Hautschäden durch Radiotherapie.
EP1007021A1 (de) Transdermale, orale und intravenöse zubereitungen von 2,3-dimethoxy-5-methyl-6-decaprenyl-1,4-benzochinon
DE69927260T2 (de) Topische pharmazeutische zusammensetzung zur behandlung von haut- oder zirkulatorischen krankheiten auf inflammatorischer, immun-, proliferativer oder degenerativer basis
EP1131063B1 (de) Hyperforin-salbe oder -creme
EP0198172B1 (de) Pharmazeutische Zubereitung
EP0668768B1 (de) Zusammensetzung zur bekämpfung von dermatomykosen und deren erregern sowie von schweissbildung und körpergeruch
DE3789958T2 (de) Verfahren und Apparat zur Bestrahlungsbehandlung, angepasst an das Frequenzspektrum des menschlichen Körpers.
EP0273407A2 (de) Mittel zur Verbesserung spezifischer Eigenschaften des Blutes
DE69205307T2 (de) Vorrichtung zum Behandeln von Akupunkturpunkten mittels elektrischen Feldern und Medikamentenionen.
DE4300969C2 (de) Verwendung von Malotilat zum Beschleunigen der Wundheilung bei Hautverbrennungen
DE202004012348U1 (de) Zubereitung zur Pflege der Haut bei Psoriasis oder Ekzem
DE69000960T2 (de) Zusammensetzung zur behandlung von pigmentierung.
DE2934090A1 (de) Therapie der hyperkeratotischen hauterkrankungen.
DE2460205A1 (de) Arzneimittel zur behandlung der dermatomykose
DE2620852A1 (de) Arzneimittel zur behandlung von alopecia areata
DE2653595C2 (de) Verfahren zum Extrahieren von embryonaler Kälberhaut, der dabei erhaltene Extrakt sowie dessen Verwendung als Wirkstoff in Mitteln zur Behandlung der Haut

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee